Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 18, 2022
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
[ Fri, Mar 18th 2022
] - WOPRAI
Thu, March 17, 2022
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
[ Thu, Mar 17th 2022
] - WOPRAI
William Plovanic Maintained (TMDX) at Strong Buy with Increased Target to $39 on, Mar 17th, 2022
William Plovanic of Canaccord Genuity, Maintained "TransMedics Group, Inc." (TMDX) at Strong Buy with Increased Target from $38 to $39 on, Mar 17th, 2022.
William has made no other calls on TMDX in the last 4 months.
There is 1 other peer that has a rating on TMDX. Out of the 1 peers that are also analyzing TMDX, all agrees with William's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $15 on, Friday, February 25th, 2022
